Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis

Mariela Bilotas, Gabriela Meresman, Stella I, Inés Stella, Sueldo C, Carlos Sueldo, Rosa Inés Barañao, Barañao RI
Fertility and sterility · 2009 · vol. 93(8) , pp. 2513–2518 · doi:10.1016/j.fertnstert.2009.08.058 · PMID:19819437 · W2015596274
article OA: bronze CC0 ⤵ 49 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the impact of aromatase inhibitors on ectopic endometrial growth and the peritoneal environment in a mouse model of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo evaluate the effect of aromatase inhibitors on ectopic endometrial growth and on the release of proangiogenic and proinflammatory factors in peritoneal fluid (PF).DesignProspective experimental study.SettingAnimal research and laboratory facility.Animal(s)Female Balb/c mice 2 months of age.Intervention(s)Mice had surgery performed to induce endometriosis-like lesions. Treatment with anastrozole or letrozole was started on either postoperative day 1 or 28 and continued for 4 weeks.Main outcome measure(s)Endometriotic lesions were counted and measured and aromatase expression, cell proliferation, and apoptosis were assessed. Vascular endothelial growth factor (VEGF) and prostaglandin E (PGE) levels were evaluated in the PF.Result(s)Endometriosis-like lesions express aromatase P-450. Treatment with either anastrozole or letrozole did not prevent lesion establishment; however, it significantly decreased the size of the endometriotic lesion. When treatment was initiated on postoperative day 1, letrozole and anastrozole decreased cell proliferation and increased apoptosis. When treatment was started on postoperative day 28, both aromatase inhibitors decreased cell proliferation, but only anastrozole augmented apoptosis levels. In addition, letrozole reduced VEGF and PGE levels in PF. Anastrozole diminished VEGF content but did not cause any significant change in PGE levels.Conclusion(s)These findings support the further investigation of aromatase inhibition as a treatment option for endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Aromatase Inhibitors Endometriosis Nitriles Triazoles Vascular Endothelial Growth Factor A Anastrozole Animals Apoptosis Apoptosis Aromatase Aromatase Aromatase Inhibitors Ascitic Fluid Ascitic Fluid Cell Proliferation Cell Proliferation Disease Models, Animal Endometriosis Endometriosis Endometrium

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (50)

Cited by (49)

Source provenance

europepmc
last seen: 2026-07-26T06:08:39.051465+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:13:59.677786+00:00
License: CC0 · commercial use OK